HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mark Hallett Selected Research

Ideomotor Apraxia

4/2022Effects of anodal stimulation and motor practice on limb-kinetic apraxia in Parkinson's disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mark Hallett Research Topics

Disease

25Parkinson Disease (Parkinson's Disease)
05/2022 - 09/2004
24Task-Specific Focal Dystonia
05/2022 - 05/2004
21Tremor (Tremors)
02/2022 - 11/2003
18Dystonia (Limb Dystonia)
12/2020 - 01/2002
16Dystonic Disorders (Writer's Cramp)
06/2022 - 01/2002
15Essential Tremor (Essential Tremors)
02/2022 - 11/2003
7Stroke (Strokes)
04/2010 - 08/2002
6Torticollis (Wryneck)
01/2020 - 06/2013
5Movement Disorders (Movement Disorder)
02/2022 - 02/2009
5Hypokinesia (Bradykinesia)
01/2020 - 03/2006
5Blepharospasm
10/2019 - 04/2013
4Tics (Tic)
01/2021 - 06/2012
3Pain (Aches)
09/2015 - 02/2004
2Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive)
05/2022 - 06/2012
2Conversion Disorder (Astasia Abasia)
11/2021 - 09/2015
2Parkinsonian Disorders (Parkinsonism)
12/2020 - 10/2008
2Dysphonia (Spastic Dysphonia)
12/2020 - 09/2013
2Alzheimer Disease (Alzheimer's Disease)
02/2020 - 09/2008
2Benign essential blepharospasm
05/2018 - 10/2010
2Dyskinesias (Dyskinesia)
01/2017 - 04/2009
2Migraine Disorders (Migraine)
05/2016 - 09/2015
2Myoclonus (Nocturnal Myoclonus)
01/2016 - 02/2005
2Dystonia musculorum deformans type 1
06/2015 - 01/2007
2Sialorrhea
11/2014 - 06/2013
2Hemifacial Spasm
11/2013 - 06/2013
2Gambling (Pathological Gambling)
08/2011 - 05/2011
2Nervous System Diseases (Neurological Disorders)
08/2010 - 03/2008
2Celiac Disease (Celiac Sprue)
05/2007 - 05/2003
2Ataxia (Dyssynergia)
04/2004 - 05/2003
1Ideomotor Apraxia
04/2022
1Disease Progression
01/2021
1Seizures (Absence Seizure)
01/2021
1Infarction (Infarctions)
12/2019
1Photophobia (Light Sensitivity)
10/2019
1Diffuse Axonal Injury
09/2018
1Gliosis
01/2018
1Synucleinopathies
01/2018
1Muscle Cramp (Cramp)
12/2017
1Atrophy
10/2016
1Tension-Type Headache (Tension Headache)
05/2016
1Headache (Headaches)
05/2016
1Binge Drinking
01/2016
1Partial Epilepsies (Epilepsy, Partial)
11/2013
1Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
10/2013

Drug/Important Bio-Agent (IBA)

16Botulinum Toxins (Botulinum Toxin)IBA
11/2019 - 12/2003
15FHDIBA
01/2018 - 05/2004
7Dopamine (Intropin)FDA LinkGeneric
01/2018 - 07/2008
6Levodopa (L Dopa)FDA LinkGeneric
01/2020 - 09/2004
6Pharmaceutical PreparationsIBA
11/2019 - 11/2003
5salicylhydroxamic acid (SHAM)IBA
02/2020 - 06/2006
5incobotulinumtoxinAFDA Link
05/2016 - 04/2010
4Biomarkers (Surrogate Marker)IBA
05/2022 - 12/2016
4gamma-Aminobutyric Acid (GABA)IBA
01/2018 - 01/2002
4octanoic acid (caprylic acid)IBA
01/2018 - 07/2012
4Type A Botulinum Toxins (Botox)FDA Link
05/2016 - 09/2008
41-Octanol (1 Octanol)IBA
04/2016 - 10/2011
4Therapeutic UsesIBA
04/2016 - 06/2006
4AntibodiesIBA
01/2016 - 05/2003
4Ethanol (Ethyl Alcohol)IBA
01/2014 - 11/2003
3AlcoholsIBA
01/2014 - 10/2011
2Proteins (Proteins, Gene)FDA Link
12/2020 - 05/2007
2PlasticsIBA
01/2020 - 03/2006
2Biological ProductsIBA
01/2017 - 09/2015
2Dopamine Receptors (Dopamine Receptor)IBA
12/2013 - 01/2007
2Carboxylic AcidsIBA
07/2012 - 10/2011
2HarmalineIBA
07/2012 - 10/2011
2Dopamine Agonists (Dopamine Agonist)IBA
05/2011 - 01/2010
2Glutens (Glutelin)IBA
05/2007 - 05/2003
1COVID-19 VaccinesIBA
11/2021
1Antipsychotic Agents (Antipsychotics)IBA
01/2021
1ElementsIBA
01/2020
1melanopsinIBA
10/2019
1Complement System Proteins (Complement)IBA
01/2019
1UbiquitinIBA
09/2018
1Amyloid (Amyloid Fibrils)IBA
09/2018
1Cholinergic Agents (Cholinergics)IBA
01/2018
1Choline O-Acetyltransferase (Choline Acetyltransferase)IBA
01/2018
1BenserazideIBA
01/2018
1Formaldehyde (Formol)FDA Link
01/2018
1Amyloid beta-PeptidesIBA
01/2018
1Dopamine D2 Receptors (Dopamine D2 Receptor)IBA
12/2017
1Dopamine D1 Receptors (Dopamine D1 Receptor)IBA
12/2017
1Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA
12/2016
1onabotulinum toxin AIBA
05/2016
1Hydrocortisone (Cortisol)FDA LinkGeneric
09/2015
1Dopamine Agents (Dopaminergic Agents)IBA
11/2014

Therapy/Procedure

24Therapeutics
01/2021 - 03/2003
23Transcranial Magnetic Stimulation
06/2022 - 10/2003
13Deep Brain Stimulation
05/2022 - 08/2010
7Injections
11/2019 - 10/2009
5Activities of Daily Living (ADL)
02/2022 - 09/2011
5Electrodes (Electrode)
09/2016 - 03/2008
4Transcranial Direct Current Stimulation
04/2022 - 10/2010
2Microelectrodes
06/2015 - 11/2004
1Ketogenic Diet
01/2021
1Psychology Biofeedback (Biofeedback)
01/2020
1Occupational Therapy (Therapy, Occupational)
11/2019
1Lenses
10/2019
1Drug Therapy (Chemotherapy)
01/2014
1Microvascular Decompression Surgery
11/2013